Ultralife (NASDAQ:ULBI) Posts Quarterly Earnings Results

Ultralife (NASDAQ:ULBI) issued its earnings results on Thursday. The technology company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.09), FiscalAI reports. Ultralife had a negative net margin of 3.50% and a positive return on equity of 2.75%. The firm had revenue of $48.27 million during the quarter, compared to the consensus estimate of $56.00 million.

Ultralife Price Performance

ULBI opened at $15.63 on Friday. The company has a market capitalization of $260.44 million, a price-to-earnings ratio of -39.08 and a beta of 0.63. The company has a quick ratio of 1.30, a current ratio of 2.87 and a debt-to-equity ratio of 0.32. The firm has a 50-day moving average price of $7.42 and a 200-day moving average price of $6.65. Ultralife has a twelve month low of $4.90 and a twelve month high of $15.69.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Ultralife in a research note on Wednesday, September 9th. One investment analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the company currently has a consensus rating of “Sell”.

Ultralife Company Profile

Ultralife Corporation is a New York-based manufacturer of power and communications products serving government, defense, aerospace, industrial, medical and other specialized markets. The company develops and produces batteries, battery packs, chargers and related power-management products designed for portable and mission-critical equipment.

Ultralife’s product portfolio includes lithium primary and rechargeable batteries, custom battery assemblies, military battery systems, charging equipment and accessories.